APO RESEARCH · REPORT
Pain Management Drugs
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
Product & engineering
Understand the product.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
Selected research
Industry Growth & Trends
Global Pain Management Drugs Industry Growth and Trends Forecast to 2032
Market perspective
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
According to APO Research, the global Pain Management Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Pain Management Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pain Management Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pain Management Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pain Management Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pain Management Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pain Management Drugs Market by Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Pain Management Drugs Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Pain Management Drugs Segment by Application
Hospitals
Drugstores
Others
Pain Management Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pain Management Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Opioids
- Branded Opioids
- NSAIDs
- Others
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- GSK
- Pfizer
- Grunenthal
- Sanofi
- Bayer
- AstraZeneca
- Eli Lilly
- Endo
- Merck
- Yunnan Baiyao
- Teikoku Seiyaku
- Teva
- J&J
- Assertio Therapeutics
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pain Management Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pain Management Drugs Market Size by Region (2021-2032)
- 1.4.1 Global Pain Management Drugs Market Size by Region (2021-2026)
- 1.4.2 Global Pain Management Drugs Market Size by Region (2027-2032)
- 1.5 Key Regions Pain Management Drugs Market Size (2021-2032)
- 1.5.1 North America Pain Management Drugs Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pain Management Drugs Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pain Management Drugs Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pain Management Drugs Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pain Management Drugs Market Size Growth Rate (2021-2032)
2 Pain Management Drugs Market by Type
- 2.1 Type Introduction
- 2.1.1 Generic Opioids
- 2.1.2 Branded Opioids
- 2.1.3 NSAIDs
- 2.1.4 Others
- 2.2 Global Pain Management Drugs Market Size by Type
- 2.2.1 Global Pain Management Drugs Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pain Management Drugs Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pain Management Drugs Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pain Management Drugs Market Size by Regions
- 2.3.1 North America Pain Management Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pain Management Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pain Management Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pain Management Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pain Management Drugs Market Size Breakdown by Type (2021-2026)
3 Pain Management Drugs Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Drugstores
- 3.1.3 Others
- 3.2 Global Pain Management Drugs Market Size by Application
- 3.2.1 Global Pain Management Drugs Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pain Management Drugs Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pain Management Drugs Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pain Management Drugs Market Size by Regions
- 3.3.1 North America Pain Management Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pain Management Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pain Management Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pain Management Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pain Management Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pain Management Drugs Industry Trends
- 4.2 Pain Management Drugs Industry Drivers
- 4.3 Pain Management Drugs Industry Opportunities and Challenges
- 4.4 Pain Management Drugs Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pain Management Drugs Revenue (2021-2026)
- 5.2 Global Pain Management Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pain Management Drugs Key Company Headquarters & Area Served
- 5.4 Global Pain Management Drugs Company, Product Type & Application
- 5.5 Global Pain Management Drugs Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pain Management Drugs Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pain Management Drugs Players Market Share by Revenue in 2025
- 5.6.3 2025 Pain Management Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 GSK Pain Management Drugs Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer Pain Management Drugs Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Grunenthal
- 6.3.1 Grunenthal Company Information
- 6.3.2 Grunenthal Business Overview
- 6.3.3 Grunenthal Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Grunenthal Pain Management Drugs Product Portfolio
- 6.3.5 Grunenthal Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sanofi Pain Management Drugs Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bayer Pain Management Drugs Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 AstraZeneca Pain Management Drugs Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Eli Lilly
- 6.7.1 Eli Lilly Company Information
- 6.7.2 Eli Lilly Business Overview
- 6.7.3 Eli Lilly Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Eli Lilly Pain Management Drugs Product Portfolio
- 6.7.5 Eli Lilly Recent Developments
- 6.8 Endo
- 6.8.1 Endo Company Information
- 6.8.2 Endo Business Overview
- 6.8.3 Endo Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Endo Pain Management Drugs Product Portfolio
- 6.8.5 Endo Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck Pain Management Drugs Product Portfolio
- 6.9.5 Merck Recent Developments
- 6.10 Yunnan Baiyao
- 6.10.1 Yunnan Baiyao Company Information
- 6.10.2 Yunnan Baiyao Business Overview
- 6.10.3 Yunnan Baiyao Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
- 6.10.5 Yunnan Baiyao Recent Developments
- 6.11 Teikoku Seiyaku
- 6.11.1 Teikoku Seiyaku Company Information
- 6.11.2 Teikoku Seiyaku Business Overview
- 6.11.3 Teikoku Seiyaku Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
- 6.11.5 Teikoku Seiyaku Recent Developments
- 6.12 Teva
- 6.12.1 Teva Company Information
- 6.12.2 Teva Business Overview
- 6.12.3 Teva Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Teva Pain Management Drugs Product Portfolio
- 6.12.5 Teva Recent Developments
- 6.13 J&J
- 6.13.1 J&J Company Information
- 6.13.2 J&J Business Overview
- 6.13.3 J&J Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 J&J Pain Management Drugs Product Portfolio
- 6.13.5 J&J Recent Developments
- 6.14 Assertio Therapeutics
- 6.14.1 Assertio Therapeutics Company Information
- 6.14.2 Assertio Therapeutics Business Overview
- 6.14.3 Assertio Therapeutics Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
- 6.14.5 Assertio Therapeutics Recent Developments
- 6.15 Allergan
- 6.15.1 Allergan Company Information
- 6.15.2 Allergan Business Overview
- 6.15.3 Allergan Pain Management Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Allergan Pain Management Drugs Product Portfolio
- 6.15.5 Allergan Recent Developments
7 North America
- 7.1 North America Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pain Management Drugs Market Size by Country (2021-2026)
- 7.3 North America Pain Management Drugs Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pain Management Drugs Market Size by Country (2021-2026)
- 8.3 Europe Pain Management Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pain Management Drugs Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pain Management Drugs Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pain Management Drugs Market Size by Country (2021-2026)
- 10.3 South America Pain Management Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pain Management Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pain Management Drugs Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pain Management Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst